Related Experiment Video
Updated: Feb 13, 2026

Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
Graft failure and recurrence of symptoms after coronary artery bypass grafting
Mikael Janiec1,2, Timo Z Nazari Shafti3,4, Axel Dimberg1,2
1a Department of Cardiothoracic Surgery and Anaesthesia , Uppsala University Hospital , Uppsala , Sweden.
Insights
Saphenous vein graft failure after coronary artery bypass grafting (CABG) is linked to recurrent coronary artery disease (CAD) symptoms. However, many angiographies without graft failure suggest other causes for symptom recurrence.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Vascular Biology
Background:
- Saphenous vein grafts (SVGs) used in coronary artery bypass grafting (CABG) often develop graft disease, leading to poor long-term patency.
- The precise clinical impact of SVG failure on recurrent coronary artery disease (CAD) symptoms remains incompletely understood.
Purpose of the Study:
- To evaluate how SVG graft failure influences the recurrence of CAD symptoms post-CABG.
- To determine the contribution of atherosclerosis progression in native coronary arteries to recurrent CAD symptoms.
Main Methods:
- Analysis of 46,663 CABG cases from the SWEDEHEART registry (2001-2015) in patients aged 40-80 years.
- Comparison of outcomes for single internal mammary artery (IMA) anastomosis, IMA with one SVG (1SVG), and IMA with multiple SVG (2+ SVG) procedures.
- Calculation of multivariable adjusted hazard ratios for mortality and postoperative coronary angiography, with recording of indications and graft failure occurrence.
Main Results:
- Mortality rates were similar across the three surgical groups (IMA, 1SVG, 2+ SVG).
- The adjusted hazard ratio for undergoing angiography was higher for IMA (1.24) and 1SVG (1.21) compared to 2+ SVG.
- Graft failure was identified in 21.4% of IMA, 41.6% of 1SVG, and 61.1% of 2+ SVG patients presenting with CAD symptoms and undergoing initial angiography.
Conclusions:
- A significant proportion of postoperative CAD symptom recurrence and subsequent angiographies occur in patients without detectable graft failure.
- Internal mammary artery (IMA) graft failure or progression of atherosclerosis in native coronary arteries are likely significant contributors to recurrent CAD symptoms.
Objectives:
Saphenous vein grafts (SVGs) most often used in coronary artery bypass grafting (CABG) are subject to graft disease and have poor long-term patency, however the clinical implication of this is not completely known. We aim to assess the influence of graft failure on the postoperative recurrence of coronary artery disease (CAD) symptoms in relation to the contribution from progression of atherosclerosis in the native coronary vessels.
Design:
Within the SWEDEHEART registry we identified 46,663 CABG cases between 2001 and 2015 with patient age 40-80 years where single internal mammary artery (IMA) anastomosis (IMA), single IMA with one (1SVG) or multiple SVG anastomoses (2+ SVG) had been performed. Clinical characteristics as well as mortality and postoperative incidence of coronary angiography were recorded and multivariable adjusted hazard ratios were calculated. Indications for the angiographies and occurrence of graft failure were also registered.
Results:
The adjusted hazard ratio for death was similar for the three groups. The adjusted hazard ratio for being submitted to angiography as compared to 2+ SVG was (95% CI) 1.24 (1.06-1.46) for IMA and 1.21 (1.15-1.28) for 1SVG. Failed grafts were found at the first postoperative angiography with preceding CAD symptoms in 21.4% of patients in the IMA group, 41.6% in the 1SVG group and 61.1% in the 2+ SVG group.
Conclusions:
A substantial amount of angiographies occur in patients without any graft failure and a large part of postoperative recurrence of CAD symptoms and are likely attributed to IMA failure or progression of atherosclerosis in the native coronary arteries.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

